VKV. O. Kleshneva

V. O. Kleshneva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


V. O. Kleshneva has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of air-filled breast tissue expander in breast cancer reconstructive surgery

    by O. S. Khodorovich, V. A. Solodkiy, Alyona A. Kalinina-Masri, A. A. Tashchyan, T. V. Sherstneva, V. O. Kleshneva, O. A. Kiryukhina

    Background. Improved quality of life for patients diagnosed with breast cancer is a consequence of modern advances in oncology surgery and the overall advantage of performing function-sparing surgery. Breast reconstruction has become an important stage of rehabilitation for patients diagnosed with cancer undergoing complex or combined treatment. Aim. To evaluate a new technique for breast reconstruction using prepectoral placement of an air-filled tissue expander. Materials and methods. The article presents data from 155 (34.4 %) of 450 patients who underwent multistep delayed reconstructions, including the stage of installing a tissue expander, which was filled with air. All patients were evaluated before surgery and with different intervals between the stages of reconstruction by photographs in five angles with the patient»s consent. 155 patients underwent immediate breast reconstruction with the installation of a tissue expander prepectorally at the first stage. The cavity of the tissue expander was filled with air. Further, after the strengthening of the covering tissues, the air content was replaced with a saline solution. The average period of restoration of the image and likeness of the mammary gland was 7.6 months (the time from the installation of the tissue expander to its replacement with a permanent silicone endoprosthesis, including the stages of combined / complex treatment, is taken into account). Results. According to the study, no postoperative complications were observed in patients who underwent immediate two-stage breast reconstruction with prepectoral placement of an air-filled tissue expander. All patients received combined / complex treatment for breast cancer within the prescribed timeframe. Conclusion. This technology has been officially patented and is being actively implemented in clinical practice. This technology allows for control of the tissue expander expansion stage with the required pressure on the integumentary tissue and the ability to balance.

  • Open Access

    Epidermal cyst of the mammary gland: a common benign formation of atypical localization

    by O. S. Khodorovich, V. A. Solodkiy, A. A. Kalinina-Masri, T. V. Sherstneva, V. O. Kleshneva, K. B. Ishchenko, P. V. Muravyova, M. A. Khodorovich

    Epidermal cysts can be located anywhere: on the scalp, face, trunk, neck and limbs. In the article, specialists from the Department of Surgical Treatment Methods and Antitumor Drug Therapy for Breast Tumors at the Mammology Clinic of the Russian Research Center of Radiology present a rare clinical case of a cyst of atypical localization and a literature review aimed at raising awareness of the existence of epidermal cysts in the parenchyma of the mammary gland. This clinical experience is also interesting from the point of view of differential diagnostics between other benign and malignant formations of the mammary gland to choose the right treatment tactics.

  • Open Access

    Breast calcifications. Literature review

    by O. S. Khodorovich, V. A. Solodkiy, V. O. Kleshneva, T. V. Sherstneva, K. V. Ishchenko, К. Б. Ищенко

    Breast cancer continues to maintain a leading position in the structure of the incidence of all oncological diseases among women. Early diagnosis of the disease at the stage of assessing indirect signs makes it possible in the future to maintain a good quality of life for patients by forming proper dynamic monitoring and performing functionally sparing surgical treatment. Interest in the early detection of benign and malignant pathology of the mammary gland is growing every year. A multidisciplinary approach to the study of the formation of breast calcifications makes it possible to look at the problem in a multifaceted way, and ways to solve problems in the process of diagnosis underlie the biochemical understanding of the mechanisms of formation, which is no less important when evaluating mammographic images. Practically up to 50 % of non-palpable breast tumors in practice are detected by signs of existing calcifications in the gland tissue. At present, the problem of early detection of malignant tumors of the breast by radiographic signs of these calcifications, their shape and nature of location in the gland tissue and their further pathomorphological confirmation is being actively studied.We have analyzed the literature data of foreign and domestic authors over the past 20 years. The problem was considered from the mechanism of formation and morphological features of calcifications in the breast tissue to their radiographic assessment on mammographic images. According to the results of the studied literature, the biochemical features of the formations were taken as the basis for understanding the nature of calcifications in the breast tissue. On a biochemical level, calcifications are usually classified into two main types: type I, consisting of calcium oxalate, and type II, consisting of hydroxyapatite. The classification is based on chemical composition and mammographic characteristics, including morphology, distribution and density. Speaking about calcium oxalate, the benign nature of education is most often implied, which cannot be said about hydroxyapatite. Mammography is the main method for diagnosing these formations, taking into account the characteristics of the characteristic radiological signs, which are also detailed in this article.Understanding the molecular and structural development of calcifications may aid in the detection and treatment of breast lesions. Identification of these structures in a patient diagnosed with breast cancer refers to the early diagnosis of the disease, where, with timely prescribed therapy, we get high chances of good long-term results of relapse-free survival.


  • Prepectoral implant-based breast reconstruction in patients with breast cancer

    by O.S. Khodorovich, V.A. Solodkiy, K.D. Sarkisyan, A.A. Kalinina-Masri, T.V. Sherstneva, V.O. Kleshneva, L.B. Kanakhina

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить результаты реконструктивных операций при раке молочной железы путем препекторальной установки имплантатов. МАТЕРИАЛ И МЕТОДЫ В исследование включены 130 пациенток с диагнозом рака молочной железы, у которых на хирургическом этапе лечения выполнена реконструктивно-пластическая операция с одномоментной препекторальной установкой эндопротеза. РЕЗУЛЬТАТЫ Имплантаты с полиуретановым покрытием использованы в 69% случаев, текстурированные имплантаты — в 31% случаев. Чаще всего (в 87% случаев) данная реконструктивная операция выполнялась у пациентов с начальными стадиями заболевания (с 0—IIa стадиями). Химиотерапевтическое лечение после операции получили 62 (47,7%) пациентки. Лучевая терапия проведена в 35 (27%) случаях, из них 60% больных — с установленным полиуретановым имплантатом и 40% больных — с установленным текстурированным имплантатом. В ряде случаев имели место осложнения, которые в большинстве своем были получены на фоне проводимого лучевого и/или химиотерапевтического лечения. ЗАКЛЮЧЕНИЕ Одномоментная реконструкция молочной железы путем препекторального размещения имплантата является надежным и доступным методом реконструкции молочной железы. Очевидно влияние лучевой терапии и химиотерапии на вероятность некоторых видов осложнений. Совершенствование хирургических методик и методов профилактики осложнений позволит в дальнейшем более эффективно использовать препекторальную установку имплантатов для реконструкции молочной железы.


  • Open Access

    Phyllodes breast tumor. From diagnostic to pathomorphological examination

    by V. A. Solodkiy, O. S. Khodorovich, A. A. Kalinina-Masri, K. D. Sarkisyan, T. V. Sherstneva, V. O. Kleshneva, L. B. Kanakhina, I. A. Lazukina, K. K. Letts-Orletsov

    Background. Phylloid tumors are a fairly rare pathology (about 0.3–0.5 % of all breast tumors), which is why there is no single protocol for the treatment of this pathology. Also, due to the lack of data and the rare occurrence, it is difficult to diagnose and choose the final management tactics of the patient. Phylloid tumors can be benign, borderline, and malignant neoplasms, which also complicates the treatment process. The final decision on the choice of patient management tactics can be made only after receiving the results of a planned pathomorphological examination.Materials and methods. In this article, we will discuss the results of major retrospective studies, including data on epidemiology, etiology, diagnostic approach, strategies and results of treatment of phylloid breast tumors, as well as present data on patients treated at the Russian Scientific Center of Radiology of the Ministry of Health of the Russian Federation for the period from January 2010 to February 2021.Results. The main methods of instrumental diagnosis of phylloid tumors are mammography, ultrasound and MRI. Morphological examination is important in making a diagnosis. Fine-needle biopsy often does not allow establishing an accurate diagnosis, and therefore the main method of diagnosis remains pathohistological examination. The main method of treatment of phylloid tumors remains surgical, where, depending on the trepan biopsy, the question of the feasibility of performing an organ-preserving operation is decided.Conclusion. Phylloid tumors are a rare type of breast neoplasm, which is the reason for the relatively small amount of scientific research that addresses this particular problem.